We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Cetuximab as Induction Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00623558
Recruitment Status : Completed
First Posted : February 26, 2008
Last Update Posted : December 4, 2013
Clinical Research Center for Solid Tumor, Korea
Information provided by (Responsible Party):
Dae Seog Heo, Seoul National University Hospital